![Jean-Marie R. Saint-Remy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Jean-Marie R. Saint-Remy first degree
Entity | Entity type | Industry | |
---|---|---|---|
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.
4
| Holding Company | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Marie R. Saint-Remy via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Docpharma NV
![]() Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
ABIVAX | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Pyxima NV
![]() Pyxima NV Packaged SoftwareTechnology Services Pyxima NV provides software services. It offers elderly care, talking books for visually impaired readers, and guides for disabled workers. The company was founded in 2009 and is located in Tessenderlo, Belgium. | Packaged Software | Director/Board Member | |
Ifast NV
![]() Ifast NV Miscellaneous Commercial ServicesCommercial Services Ifast NV develops and commercializes intellectual property, technology and know-how related to the organoleptic and functional properties of foods and beverages. It offers services to the corporate and public sectors. The company was founded by Pascal Mertens in 2012 and is headquartered in Roosdaal, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Katholieke Universiteit Leuven | College/University | Graduate Degree | |
KPMG Bedrijfsrevisoren
![]() KPMG Bedrijfsrevisoren Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG Bedrijfsrevisoren is a company based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Senior Living Group NV
![]() Senior Living Group NV Hospital/Nursing ManagementHealth Services Senior Living Group NV owns and operates residential care and nursing homes. The company is headquartered in Kontich, Belgium. | Hospital/Nursing Management | Corporate Officer/Principal | |
Leuven innovatie VZW | Corporate Officer/Principal | ||
Aeschylus R&d Philanthropy | Corporate Officer/Principal | ||
QAELUM NV
![]() QAELUM NV Medical/Nursing ServicesHealth Services QAELUM NV provides breast cancer screening programs and patient radiation dose monitoring services. The firm specializes in quality assurance of breast cancer screening programs and patient radiation dose monitoring for any digital modality. Its solutions allow healthcare institutions (hospitals, clinics), private practices and OEM partners to perform more relevant quality control and improve workflow efficiently. The company was founded by Raymond Herman Ghislain Oyen, Hilde Theresia Constant Bosmans, Jurgen Jacobs, Relinde Carine Francine Marie Therese Stessens and Louis Donald Maurice Deaulmerie in 1997 and is headquartered in Leuven, Belgium.^^ ^^ | Medical/Nursing Services | Director of Finance/CFO | |
Amyl Therapeutics SRL
![]() Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | Biotechnology | Chief Executive Officer | |
Facultés Universitaires Notre-Dame de la Paix | College/University | Doctorate Degree | |
Uteron Pharma SA
![]() Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Equipment/Instruments | Chief Executive Officer | |
Ghent University | College/University | Doctorate Degree | |
AstraZeneca, Inc.
![]() AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer | |
NEOVACS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Hyloris Developments SA
![]() Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Hyloris Developments SA is a Belgian pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Liege, Belgium. The company was founded in 2013. The CEO is Stijn van Rompay. | Pharmaceuticals: Major | Chief Executive Officer | |
Coalesce Product Development Ltd.
![]() Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022. | Medical Specialties | Director/Board Member | |
EXO Biologics SA
![]() EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
University of Antwerp | College/University | Graduate Degree | |
HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Founder | |
Alter Pharma Group NV
![]() Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Alter Pharma Group NV manufactures and distributes pharmaceutical products. The company was founded in 2006 and is headquartered in Anderlecht, Belgium. | Pharmaceuticals: Major | Founder | |
Mindspeller BV
![]() Mindspeller BV Advertising/Marketing ServicesCommercial Services Mindspeller Bvba provides marketing and advertising services. The company was founded by Marc Van Hulle and Hannes de Wachter and is headquartered in Leuven, Belgium. | Advertising/Marketing Services | Chief Executive Officer |
Statistics
International
Belgium | 21 |
France | 3 |
United States | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 12 |
Consumer Services | 5 |
Commercial Services | 4 |
Health Services | 3 |
Technology Services | 2 |
Operational
Director/Board Member | 11 |
Chief Executive Officer | 9 |
Corporate Officer/Principal | 7 |
Founder | 5 |
Director of Finance/CFO | 4 |
Most connected contacts
Insiders | |
---|---|
Hannes de Wachter | 10 |
Stijn van Rompay | 9 |
Pierre Vandepapeliere | 8 |
Marie Gérard | 1 |
- Stock Market
- Insiders
- Jean-Marie R. Saint-Remy
- Company connections